Nicobrand Limited in County Londonderry, BT51 3RP

Description

Data updated on: 01-11-2023

Registered as NI033276 twenty seven years ago, Nicobrand Limited is a Private Limited Company. The active mailing address is 189 Castleroe Road, Coleraine County Londonderry. The firm's classified under the NACE and SIC code 21200 and has the NACE code: Manufacture of pharmaceutical preparations. The most recent annual accounts were submitted for the period up to December 31, 2022 and the most recent annual confirmation statement was released on November 17, 2022.

Helen B. and Mark M. are listed as company's directors and have been working on the company success for 13 years.

The companies that control this firm include: Contraf -Nicotex-Tobacco Gmbh owns over 3/4 of company shares and has 3/4 to full of voting rights. This business can be reached in Heilbronn at D-74004 and was registered as a PSC under the registration number 925828082.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
Currency

Balance Sheet
Cash Bank On Hand	254 446	369 022	657 252	1 278 073	776 572	6 307 611	2 139 628
Current Assets	21 046 098	25 270 540	32 307 680	5 376 167	5 955 566	12 448 438	15 019 501
Debtors	17 273 563	2 718 719	29 882 450	2 292 436	2 927 793	2 998 007	5 669 848
Net Assets Liabilities	22 277 109	26 731 326	32 712 219	6 686 136	8 336 703	14 402 974	16 429 460
Other Debtors	225 811	351 458	5 174	139 992	151 425	90 512	105 849
Property Plant Equipment	2 486 299	2 756 472	2 589 274	2 555 773	3 873 451	3 931 551	5 337 671
Total Inventories	995 138	980 023	1 767 978	1 805 658	2 251 201	3 142 820	7 210 025

Other Financial Data
Audit Fees Expenses	8 900	8 900	8 900	8 900	9 500	9 500	11 000
Accrued Liabilities Deferred Income	305 464	187 980	422 914	277 550	368 561	364 688	184 629
Accumulated Amortisation Impairment Intangible Assets	2 471 116	2 605 600	2 689 649	2 689 649	2 689 649	2 689 649
Accumulated Depreciation Impairment Property Plant Equipment	6 243 507	6 542 237	6 884 297	7 228 959	7 695 705	8 392 398	9 340 356
Additions Other Than Through Business Combinations Property Plant Equipment		568 903	174 862	326 661	1 784 424	754 793	2 354 078
Administrative Expenses	631 469	504 984	584 311	940 103	1 646 463	2 009 146	2 538 817
Amortisation Expense Intangible Assets	78 449	134 484	84 049
Amortisation Impairment Expense Intangible Assets			84 049
Amounts Owed By Group Undertakings		21 202 776	25 263 118
Average Number Employees During Period	28	29	29	31	33	39	40
Cash Cash Equivalents Cash Flow Value		369 022	657 252	1 278 073	776 572	6 307 611	2 139 628
Corporation Tax Payable	925 968	1 076 523	1 019 828	342 020	25 599	831 761	365 282
Cost Sales	5 782 600	6 039 783	7 226 357	5 521 375	4 479 561	7 879 744	8 727 361
Creditors	4 421	3 605	2 789	1 973	1 157	1 688 704	4 372
Current Tax For Period	925 968	1 060 253	1 489 065	778 021	245 333	1 398 497	1 005 169
Deferred Income	4 421	3 605	2 789	1 973	1 157		4 372
Deferred Tax Asset Debtors	26 159	43 990	30 185
Deferred Tax Expense Credit From Unrecognised Timing Difference From Prior Period				22 377
Deferred Tax Expense Credit Relating To Origination Reversal Timing Differences	24 822	-17 831	13 805	55 913	178 122	62 084	-18 053
Depreciation Expense Property Plant Equipment	228 555	298 730	342 060	360 162	466 746	696 693	947 958
Depreciation Impairment Expense Property Plant Equipment			342 060	360 162	466 746	696 693	947 958
Dividends Paid				29 411 758			1 989 518
Dividends Paid Classified As Financing Activities				-29 411 758			-1 989 518
Dividends Paid On Shares Final				29 411 758			1 989 518
Finished Goods Goods For Resale	637 410	620 362	795 711	710 126	502 362	1 440 513	1 976 691
Fixed Assets	2 704 832	2 840 521	2 589 274
Further Item Deferred Expense Credit Component Total Deferred Tax Expense	-50 981			22 377
Further Item Interest Expense Component Total Interest Expense					3 197
Further Item Tax Increase Decrease Component Adjusting Items	15 690	-55 805	64 991	28 952	33 935	-9 098	-16 142
Gain Loss Due To Foreign Exchange Differences Recognised In Profit Or Loss	13 958	38 831	31 125	-91 144	40 051	-47 695	124 089
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables			-862 511	308 412	-385 625	382 388	-2 430 857
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables			5 974 760	-27 559 829	635 357	70 214	2 671 841
Gain Loss In Cash Flows From Change In Deferred Income			816	816	816
Gain Loss In Cash Flows From Change In Inventories			787 955	37 680	445 543	891 619	4 067 205
Gain Loss On Disposals Property Plant Equipment				10 000
Government Grant Income					10 000	142 971	46 433
Gross Profit Loss	5 172 869	5 941 447	8 102 430	5 006 065	3 635 499	9 349 696	7 410 041
Income Taxes Paid Refund Classified As Operating Activities		-894 471	-1 800 770	-1 455 829	-492 074	-556 216	-1 410 733
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation			-288 230	-620 821	501 501	-5 531 039	4 167 983
Increase Decrease In Current Tax From Adjustment For Prior Periods		-15 227	255 010		-69 680	-36 119	-60 915
Increase From Amortisation Charge For Year Intangible Assets		134 484	84 049
Increase From Depreciation Charge For Year Property Plant Equipment		298 730	342 060	360 162	466 746	696 693	947 958
Intangible Assets	218 533	84 049
Intangible Assets Gross Cost	2 689 649	2 689 649	2 689 649	2 689 649	2 689 649	2 689 649
Interest Expense On Bank Overdrafts Bank Loans Similar Borrowings	1 522	1 824	1 865	2 009	2 857	3 774	6 240
Interest Income From Group Undertakings Participating Interests	67 021	50 543	219 125	171 336
Interest Income On Bank Deposits							246
Interest Income On Financial Assets That Are Not Fair Value Through Profit Or Loss			219 125	171 336			246
Interest Paid Classified As Operating Activities						-3 774	-6 240
Interest Payable Similar Charges Finance Costs	1 522	11 729	7 651	5 327	6 054	3 774	6 240
Interest Received Classified As Investing Activities	-67 021	-50 543	-219 125	-171 610	-384	-916	-8 868
Key Management Personnel Compensation Total			225 710	354 088	416 218	336 772	369 342
Net Cash Flows From Used In Financing Activities				29 411 758
Net Cash Flows From Used In Investing Activities			-44 263	145 051	1 784 040
Net Cash Flows From Used In Operating Activities			-243 967	-30 177 630	-1 282 539	-6 284 916
Net Cash Generated From Operations			-2 052 388	-31 638 786	-1 780 667	-6 844 906	-1 583 718
Net Current Assets Liabilities	19 576 698	23 894 410	30 125 734	4 180 441	4 690 636	10 759 734	11 366 419
Net Finance Income Costs	67 021	50 543	219 125	171 610	384	916	8 868
Net Interest Paid Received Classified As Operating Activities	-1 522	-11 729	-7 651	-5 327	-6 054	-3 774
Number Shares Issued Fully Paid		2 285 000	2 285 000	2 285 000	2 285 000	2 285 000	2 285 000
Operating Profit Loss	4 545 100	5 442 598	7 527 299	4 075 703	2 010 012	7 493 591	4 939 577
Other Disposals Decrease In Depreciation Impairment Property Plant Equipment				15 500
Other Disposals Property Plant Equipment				15 500
Other Interest Income				274	384	916	8 622
Other Interest Receivable Similar Income Finance Income	67 021	50 543	219 125	171 610	384	916	8 868
Other Operating Income Format1	3 700	6 135	9 180	9 740	20 976	153 041	68 353
Other Taxation Social Security Payable	25 511	25 921	23 212	27 707	31 751	33 788	31 854
Par Value Share		1	1	1	1	1	1
Pension Other Post-employment Benefit Costs Other Pension Costs	35 305	40 439	43 412	47 553	55 388	67 108	70 110
Prepayments Accrued Income	46 486	83 383	106 768	171 664	192 686	132 617	140 919
Proceeds From Sales Property Plant Equipment				-10 000
Profit Loss	3 710 790	4 454 217	5 980 893	3 385 675	1 650 567	6 066 271	4 016 004
Profit Loss On Ordinary Activities Before Tax	4 610 599	5 481 412	7 738 773	4 241 986	2 004 342	7 490 733	4 942 205
Property Plant Equipment Gross Cost	8 729 806	9 298 709	9 473 571	9 784 732	11 569 156	12 323 949	14 678 027
Provisions For Liabilities Balance Sheet Subtotal				48 105	226 227	288 311	270 258
Purchase Property Plant Equipment	-351 461	-568 903	-174 862	-326 661	-1 784 424	-754 793	-2 354 078
Raw Materials Consumables	357 728	359 661	972 267	1 095 532	1 748 839	1 702 307	5 233 334
Social Security Costs	130 398	112 954	95 990	122 363	136 544	154 503	178 159
Staff Costs Employee Benefits Expense	1 344 479	1 173 187	1 266 590	1 304 841	1 506 843	1 734 695	1 693 767
Taxation Including Deferred Taxation Balance Sheet Subtotal				48 105	226 227	288 311	270 258
Tax Decrease Increase From Effect Revenue Exempt From Taxation				1 020	155	220	93
Tax Expense Credit Applicable Tax Rate			1 470 367	805 977	380 825	1 423 239	939 019
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss				25	8 850	-1 551	-53
Tax Tax Credit On Profit Or Loss On Ordinary Activities	899 809	1 027 195	1 757 880	856 311	353 775	1 424 462	926 201
Total Assets Less Current Liabilities	22 281 530	26 734 931	32 715 008	6 736 214	8 564 087	14 691 285	16 704 090
Total Current Tax Expense Credit	925 968	1 045 026	1 744 075	778 021	175 653	1 362 378	944 254
Total Deferred Tax Expense Credit	-26 159	-17 831	13 805	78 290	178 122
Trade Creditors Trade Payables	192 051	18 311	694 062	548 449	839 019	458 467	3 071 317
Trade Debtors Trade Receivables	2 224 495	2 239 888	4 477 205	1 980 780	2 583 682	2 774 878	5 423 080
Turnover Revenue	10 955 469	11 981 230	15 328 787	10 527 441	8 115 060	17 229 440	16 137 402
Wages Salaries	1 178 776	1 019 794	1 127 188	1 134 925	1 314 911	1 513 084	1 445 498
Company Contributions To Defined Benefit Plans Directors	7 876	7 947	8 101	8 308	9 508	9 588	9 588
Director Remuneration					356 599	289 843	316 656
Director Remuneration Benefits Including Payments To Third Parties			225 710	316 336	366 107	299 431	326 244

Company staff

Helen B.

Role: Secretary

Appointed: 19 January 2016

Latest update: 11 March 2024

Helen B.

Role: Director

Appointed: 26 August 2011

Latest update: 11 March 2024

Mark M.

Role: Director

Appointed: 26 August 2011

Latest update: 11 March 2024

Dean C.

Role: Director

Appointed: 12 July 2018

Resigned: 30 July 2019

Latest update: 11 March 2024

Pinsent Masons Secretarial Limited

Role: Corporate Secretary

Contraf -Nicotex-Tobacco Gmbh

Address: Herbstrasse 8 D-74004, Heilbronn, PO Box 143, Germany

Legal authority Private Limited

Legal form Private Limited

Country registered Germany

Place registered German Registry

Registration number 925828082

Notified on 1 July 2019

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Teva Pharmaceutical Industries Limited

Address: 5 Basel Street, Petach Tikva, Israel 49131, Israel

Legal authority Limited Liability

Legal form Private Limited Company

Country registered Israel

Place registered Israel

Registration number 520013954

Notified on 2 August 2016

Ceased on 28 June 2019

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Accounts Documents

Account next due date	30 September 2024
Account last made up date	31 December 2022
Confirmation statement next due date	01 December 2023
Confirmation statement last made up date	17 November 2022

Annual Accounts
Start Date For Period Covered By Report	2017-01-01
End Date For Period Covered By Report	2017-12-31
Annual Accounts
Start Date For Period Covered By Report	2018-01-01
End Date For Period Covered By Report	2018-12-31
Annual Accounts
Start Date For Period Covered By Report	2019-01-01
End Date For Period Covered By Report	2019-12-31
Annual Accounts
Start Date For Period Covered By Report	2020-01-01
End Date For Period Covered By Report	2020-12-31
Annual Accounts
Start Date For Period Covered By Report	2021-01-01
End Date For Period Covered By Report	2021-12-31
Annual Accounts
Start Date For Period Covered By Report	2022-01-01
End Date For Period Covered By Report	2022-12-31

Nicobrand Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Helen B.

Helen B.

Mark M.

Dean C.

Pinsent Masons Secretarial Limited

Robert W.

Ronald M.

Robert S.

Paul B.

David B.

Allen C.

David L.

John H.

David B.

People with significant control

Contraf -Nicotex-Tobacco Gmbh

Teva Pharmaceutical Industries Limited

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest companies